Atlas Trials

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430

Clinical trial NCT01748838 · COMPLETED

Trial details

NCT number
NCT01748838
Sponsor
Celtaxsys, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Inflammation
Start date
2012-12-01
Primary completion
2013-07-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.